GENSET - GENXY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENSET - GENXY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (193)	6/18/2002 12:25:47 PM
From: Mike McFarland	Read Replies (1) of 200

Genset Announces US Patent Allowance Covering Fluorescent Probes For Research And Diagnosis In Cytogenetics genxy.com The shares were trading up 30 cents to 1.38 around Noon today. Previously Genset announced the following management changes: Hiroaki Tanaka appointed VP Bioinformatics (replacing Robert Abarbanel, Chief Information Officer & Chief Technology Officer) John Lucas, appointed VP Intellectual Property Denis Ravel appointed Head of the San Diego Research Center, replacing John Ford. Malcolm Bates appointed General Counsel, replacing Jonathan Burnham.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next